RossMH,PawlinaW.,Histology, 2011.Chapter 24,Baltimore MD. 6th Edition 897 -916
WernerL,ChewJ,MamalisN., 2006.Experimental evaluation of ophthalmic devices and solutions using rabbit models,Veterinary Ophthalmology 9 281 -91
GhemtioL,XhaardH,UrttiA,KidronH, 2016.Predictive modeling of ocular pharmacokinetics and adverse effects,Current Pharmaceutical Design 22 6928 -34
Sánchez-LópezE,EspinaM,DoktorovovaS,SoutoE,GarcíaM., 2017.Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the Eye-Part I-Barriers and determining factors in ocular delivery,Eur J Pharm Biopharm 110 70 -5
BonneterreJ,ThurlimannB,RobertsonJ,KrzakowskiM,MauriacL,KoralewskiP, 2000.Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study,J Clin Oncol 18 3748 -57
TurakaK,NottageJM,HammersmithKM,NagraPK,RapuanoCJ, 2013.Dry eye syndrome in aromatase inhibitor users,Clinical & experimental ophthalmology 41 239 -43
MehraV,MinassianD., 1988.A rapid method of grading cataract in epidemiological studies and eye surveys,Br J Ophthalmol 72 801 -3
MoschosMM,ChatziralliIP,SergentanisT,ZagouriF,ChrysikosD,LadasI, 2016.Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors,Cutaneous and ocular toxicology 35 13 -20
SriprasertI,WarrenDW,MircheffAK,StanczykFZ, 2016.Dry eye in postmenopausal women: A hormonal disorder,Menopause 23 343 -51
GwonA., 2008.The rabbit in cataract/IOL surgery,Animal models in eye research 184 -204
GorinMB,DayR,CostantinoJP,FisherB,RedmondCK,WickerhamL, 1998.Long-term tamoxifen citrate use and potential ocular toxicity,Am J Ophthalmol 125 493 -501
ZhangJJ,JacobT,ValverdeMA,HardySP,MintenigGM,SepulvedaFV, 1994.Tamoxifen blocks chloride channels. A possible mechanism for cataract formation,J Clin Invest 94 1690 -
DulleyP,SeniorJ,Tamoxifen,Issue2,PDulley,JSenior, 2003.A review of drug development for use in breast cancer and ocular adverse reactions,Optometry in Practice 4 117 -27
PapathanassiouM,NikitaE,TheodossiadisP,TheodossiadisGP,VergadosI, 2010.Exemestane-induced corneal epithelial changes,Cutaneous and ocular toxicology 29 209 -11
SmithCL, 2004.Coregulator function: A key to understanding tissue specificity of selective receptor modulators,Endocrine Reviews 25 45 -71
EisnerA,Luoh SW, 2011.Breast cancer medications and vision: effects of treatments for early-stage disease,Current Eye Research 36 867 -85